Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Public ClinicalTrials.gov record NCT03932201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Observational Study Evaluating Effectiveness and Safety of Real-World Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A
Study identification
- NCT ID
- NCT03932201
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 371 participants
Conditions and interventions
Conditions
Interventions
- Damoctocog alfa pegol (Jivi, Bay94-9027) Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2019
- Primary completion
- Dec 30, 2026
- Completion
- Mar 30, 2027
- Last update posted
- Apr 8, 2026
2019 – 2027
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| South Alabama Medical Science Foundation | Mobile | Alabama | 36688 | — |
| Banner MD Anderson Cancer Center | Phoenix | Arizona | 85012 | — |
| University California Davis | Davis | California | 95616 | — |
| Orthopaedic Hospital DBA Orthopaedic Institute for Children | Los Angeles | California | 90007 | — |
| The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders | Orange | California | 92868 | — |
| University of Colorado Hemophilia and Thrombosis Center | Aurora | Colorado | 80045 | — |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| Regents of University of Minnesota | Minneapolis | Minnesota | 55454 | — |
| East Carolina University - Brody School of Medicine | Greenville | North Carolina | 27834 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03932201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03932201 live on ClinicalTrials.gov.